Company Info
Phone(888) 734-8587
Year Established
2007
Ticker
RGLS
Exchange
NASDAQ
Contacts
Joseph HaganPresident & CEO
Cris Calsada
CFO
Christopher Aker, J.D.
General Counsel
Curtis A. Monnig, Ph.D.
VP, CMC
Brian K. Campion, Ph.D.
VP, Business Development
Preston S. Klassen, M.D.
President, Head R&D
Company Description
Regulus Therapeutics, is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.
